|
 |
 |
|
 |
 |
GDx Access™
With the GDx Access it is now possible to detect glaucoma at a much earlier stage than ever before. This is especially significant because glaucoma typically causes no symptoms in the early stages.
Why we've invested in GDx Access™:
- GDx Access can detect glaucoma long before patients begin to lose their sight, allowing treatment to be initiated to preserve maximum vision.
- GDx Access uses a safe, infrared laser to measure the thickness of the retinal nerve fiber layer, allowing doctors to determine early on whether structural damage has been done to the eye.
- The patented GDx Access is the only screening technology available that directly and objectively evaluates the nerve fiber layer of the eye.
- The GDx Access screening test is a comfortable, in-office procedure that does not require pupil dilation or drops in the eye.
- The traditional eye pressure check is unable to detect glaucoma in many patients - 50 percent of glaucoma patients do not have high or abnormal pressure results. This device can identify those patients.
For more information about glaucoma and GDx Access go to www.laserdiagnostic.com/products/. |
|
  |
 |
| · |
Bradley C. Black, M.D. |
| · |
Steven Howell, M.D. |
| · |
Curtis Jordan, M.D. |
| · |
Kristopher R. Pugh, M.D. |
| · |
Shlomit Schaal, M.D.,Ph.D. |
| · |
Michael Dankovich, O.D. |
| · |
Mindy Gunn, O.D. |
| · |
Carolyn Hall, O.D. |
| · |
Jessica L. Pugh, O.D. |
| · |
Lindsay Swearingen, O.D. |
|
|
 |
 |
| · |
Schedule a consultation with our doctors. Tell us when you would like to visit. |
|
|
 |
|
Sign up for email news updates. Enter your email address and hit enter.
|
|
|
|